Advertisement

Current Diabetes Reports

, Volume 10, Issue 3, pp 242–247 | Cite as

New Insights on Glucose Pathophysiology in Gestational Diabetes and Insulin Resistance

  • Avi HarlevEmail author
  • Arnon Wiznitzer
Article

Abstract

Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy. The definition of GDM does not preclude the possibility that unrecognized glucose intolerance may have existed before the pregnancy, and the definition applies whether insulin, oral antidiabetic agents, or dietary modification is used for treatment. Approximately 7% of all pregnancies in the United States are complicated by gestational diabetes resulting in more than 200,000 cases annually, but the prevalence ranges from 1% to 14% of all pregnancies depending on the population studied and the diagnostic tests used. Despite the better detection of GDM and recognition of its adverse consequences for mother and baby in many countries, there is still no consensus regarding GDM pathophysiology; as a result, diagnosis and treatment of GDM remain controversial. A better understanding of obesity along with new studies in GDM has identified the intra-abdominal metabolically active adipose tissue as a major factor in the pathophysiology of GDM. This review examines recent research regarding the link between obesity and glucose intolerance and highlights studies in the areas of genetics, glucose transport, and adipokines.

Keywords

Gestational diabetes mellitus (GDM) Pathophysiology Adiposity, Intra-abdominal fat 

Notes

Disclosure

No potential conflicts of interest relevant to this article were reported.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group [no authors listed]. Diabetes 1979, 28:1039–1057.Google Scholar
  2. 2.
    American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29(Suppl 1):S43–S48.Google Scholar
  3. 3.
    Jarrett RJ: Gestational diabetes: a non-entity? BMJ 1993, 306:37–38.CrossRefPubMedGoogle Scholar
  4. 4.
    Metzger BE, Buchanan TA, Coustan DR, et al.: Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007, 30(Suppl 2):S251–S260.CrossRefPubMedGoogle Scholar
  5. 5.
    Gottlieb AG, Galan HL: Shoulder dystocia: an update. Obstet Gynecol Clin North Am 2007, 34:501–531, xii.CrossRefPubMedGoogle Scholar
  6. 6.
    Henriksen T: The macrosomic fetus: a challenge in current obstetrics. Acta Obstet Gynecol Scand 2008, 87:134–145.CrossRefPubMedGoogle Scholar
  7. 7.
    Reece EA, Leguizamon G, Wiznitzer A: Gestational diabetes: the need for a common ground. Lancet 2009, 373:1789–1797.CrossRefPubMedGoogle Scholar
  8. 8.
    •• Langer O: From educated guess to accepted practice: the use of oral antidiabetic agents in pregnancy. Clin Obstet Gynecol 2007, 50:959–971. This is a review summarizing the current data regarding all oral antidiabetic agents groups for treating GDM, supporting the randomized controlled trial published in 2000 by Langer et al.Google Scholar
  9. 9.
    Wiznitzer A, Mayer A, Novack V, et al.: Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol 2009, 201:482.e1–482.e8.Google Scholar
  10. 10.
    Shaat N, Groop L: Genetics of gestational diabetes mellitus. Curr Med Chem 2007, 14:569–583.CrossRefPubMedGoogle Scholar
  11. 11.
    Shaat N, Karlsson E, Lernmark A, et al.: Common variants in MODY genes increase the risk of gestational diabetes mellitus. Diabetologia 2006, 49:1545–1551.CrossRefPubMedGoogle Scholar
  12. 12.
    Shaat N, Lernmark A, Karlsson E, et al.: A variant in the transcription factor 7-like 2 (TCF7L2) gene is associated with an increased risk of gestational diabetes mellitus. Diabetologia 2007, 50:972–979.CrossRefPubMedGoogle Scholar
  13. 13.
    Robitaille J, Grant AM: The genetics of gestational diabetes mellitus: evidence for relationship with type 2 diabetes mellitus. Genet Med 2008, 10:240–250.CrossRefPubMedGoogle Scholar
  14. 14.
    Enquobahrie DA, Williams MA, Qiu C, et al.: Global placental gene expression in gestational diabetes mellitus. Am J Obstet Gynecol 2009, 200:206.e1–206.e13.CrossRefGoogle Scholar
  15. 15.
    Friedman JE, Ishizuka T, Shao J, et al.: Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 1999, 48:1807–1814.CrossRefPubMedGoogle Scholar
  16. 16.
    Pajvani UB, Du X, Combs TP, et al.: Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 2003, 278:9073–9085.CrossRefPubMedGoogle Scholar
  17. 17.
    Chen J, Tan B, Karteris E, et al.: Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 2006, 49:1292–1302.CrossRefPubMedGoogle Scholar
  18. 18.
    Cortelazzi D, Corbetta S, Ronzoni S, et al.: Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf) 2007, 66:447–453.CrossRefGoogle Scholar
  19. 19.
    Palik E, Baranyi E, Melczer Z, et al.: Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance. Diabetes Res Clin Pract 2007, 76:351–357.CrossRefPubMedGoogle Scholar
  20. 20.
    Zhou Y, Zhang M, Guo W, et al.: Expression of resistin protein in normal human subcutaneous adipose tissue and pregnant women subcutaneous adipose tissue and placenta. J Huazhong Univ Sci Technolog Med Sci 2006, 26:288–291.PubMedCrossRefGoogle Scholar
  21. 21.
    Megia A, Vendrell J, Gutierrez C, et al.: Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol 2008, 158:173–178.CrossRefPubMedGoogle Scholar
  22. 22.
    Vitoratos N, Vlahos NF, Gregoriou O, et al.: Maternal and umbilical resistin levels do not correlate with infant birth weight either in normal pregnancies and or in pregnancies complicated with gestational diabetes. J Matern Fetal Neonatal Med 2010 Jan 19 [Epub ahead of print].Google Scholar
  23. 23.
    • Rudich A, Kanety H, Bashan N: Adipose stress-sensing kinases: linking obesity to malfunction. Trends Endocrinol Metab 2007, 18:291–299. This is a study reviewing the concept of stress signaling in obesity, directing future investigation of different OM tissue stress.Google Scholar
  24. 24.
    Bashan N, Dorfman K, Tarnovscki T, et al.: Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology 2007, 148:2955–2962.CrossRefPubMedGoogle Scholar
  25. 25.
    Harman-Boehm I, Bluher M, Redel H, et al.: Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007, 92:2240–2247.CrossRefPubMedGoogle Scholar
  26. 26.
    Cancello R, Tordjman J, Poitou C, et al.: Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006, 55:1554–1561.CrossRefPubMedGoogle Scholar
  27. 27.
    •• Bluher M, Bashan N, Shai I, et al.: Activated Ask1-MKK4-p38MAPK/JNK stress signaling pathway in human omental fat tissue may link macrophage infiltration to whole-body insulin sensitivity. J Clin Endocrinol Metab 2009, 94:2507–2515. This is an important study establishing the association between stress signaling pathway in human OM fat to obesity and a possible connection to macrophage infiltration.Google Scholar
  28. 28.
    Harlev A, Rudich A, Bashan N, et al.: Stress-signaling in subcutaneous versus omental adipose tissue in normal and GDM pregnancies: comparison to obesity-associated adipose tissue alterations. Presented at the Society for Maternal-Fetal Medicine 29th Annual Meeting. San Diego, CA; January 26–31, 2009.Google Scholar
  29. 29.
    Weisberg SP, McCann D, Desai M, et al.: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796–1808.PubMedGoogle Scholar
  30. 30.
    Cinti S, Mitchell G, Barbatelli G, et al.: Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005, 46:2347–2355.CrossRefPubMedGoogle Scholar
  31. 31.
    Curat CA, Miranville A, Sengenes C, et al.: From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004, 53:1285–1292.CrossRefPubMedGoogle Scholar
  32. 32.
    Cancello R, Tordjman J, Poitou C, et al.: Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006, 55:1554–1561.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologySoroka University Medical CenterBeer-ShevaIsrael

Personalised recommendations